Good news for fellow Frosties with Lupus! HEALTH INDUSTRY MARCH 9, 2011, 6:22 P.M. ET Wall Street Journal The Food and Drug Administration approved a new lupus drug from Human Genome Sciences Inc. and GlaxoSmithKline PLC, marking the first new treatment for the autoimmune disease in more than 50 years.
Modified-Release Therapy is Well Tolerated in Clinical Trial Researchers in Europe reported that treatment with modified-release sildenafil significantly reduced the frequency of attacks of Raynaud’s phenomenon in patients with limited cutaneous systemic sclerosis (lcSSc), also known as scleroderma. The double-blind, placebo-controlled trial found that sildenafil was well tolerated with only some subjects experiencing minor
Sound Familiar??? http://www.cnn.com/2011/HEALTH/03/02/thermostat.arguments/
Rare Disease Day was established in 2008 to raise awareness about rare diseases, which together impact millions of people worldwide. While the Raynaud’s population is too large to be considered in this category, many among us with secondary Raynaud’s suffer from these rare medical conditions.
Raynaud's Phenomenon: More Common Than You Think By Laurie Saloman Quality Health "...understand that Raynaud's disease is far from rare. Estimates are that anywhere from five to 10 percent of people have it, with women nine times more likely to be affected than men. The peak age for diagnosis is between 15 and 30 years